Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2012 Feb;76(2):228–235. doi: 10.1111/j.1365-2265.2011.04187.x

Figure 1.

Figure 1

Change (Δ) of total T4 (A), height velocity (HV, B), plasma NTproCNP (C), and BSAP (D) from baseline in response to treatment of subjects with hypo- (left) and hyperthyroidism (right). Visit 4 corresponds to 4-6 wk and visit 9 to approximately 24 wk after commencing treatment.